Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM24 | O15164 | 1/20 | 0.35 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.35 |
| ▸ | DAO | P14920 | 1/20 | 0.32 |
| ▸ | CCR1 | P32246 | 1/20 | 0.32 |
| ▸ | CCR5 | P51681 | 1/20 | 0.32 |
| ▸ | CCR8 | P51685 | 1/20 | 0.32 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.31 |
| ▸ | PRKCI | P41743 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32679735 | 1.00 | TRIM24 (0.35) | TRIM24TRIM33DAOCCR1CCR5 | |
| SCHEMBL12468652 | 0.78 | CCR1 (0.34) | CCR1CCR5CCR8 | |
| SCHEMBL29544937 | 0.75 | NFE2L2 (0.35) | DAOCCR1CCR5CCR8PRKCI | |
| SCHEMBL14691566 | 0.75 | NFE2L2 (0.35) | DAOCCR1CCR5CCR8PRKCI | |
| SCHEMBL3719916 | 0.75 | TRIM24 (0.35) | TRIM24TRIM33DAOCCR1CCR5 | |
| SCHEMBL28858319 | 0.75 | TRIM24 (0.35) | TRIM24TRIM33DAOCCR1CCR5 | |
| SCHEMBL12468608 | 0.75 | CCR1 (0.35) | CCR1CCR5CCR8 | |
| SCHEMBL28306648 | 0.75 | TRIM24 (0.32) | TRIM24TRIM33DAO | |
| SCHEMBL14691512 | 0.72 | NFE2L2 (0.37) | CCR1CCR5CCR8 | |
| SCHEMBL21569208 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4574822-A2 | COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS | Kamari Pharma Ltd. (IL) | 2025-06-25 | — | — | EP | disclosed |
| EP-4096661-A1 | COMPOUNDS AND COMPOSITIONS FOR USE IN TREATING SKIN DISORDERS | Kamari Pharma Ltd. (IL) | 2022-12-07 | — | — | EP | disclosed |
| WO-2008144463-A1 | QUINOLINE DERIVATIVES AS PI3 KINASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-11-27 | — | — | WO | disclosed |